ResultsIQ › Latest results › Paras Healthcare Limited
Paras Healthcare Limited Q2 FY27 earnings call summary
NSE: PARASHLTH · BSE: 545005
Earnings call of 6 Nov 2026, summarised by AI from the filing.
Paras Healthcare Q2 FY27 revenue ₹511 cr, up 23%, operating EBITDA ₹120 cr, up 47%, with new hospitals turning EBITDA positive.
Key takeaways
- Q2 revenue Revenue ₹511 cr, up 23% year-on-year; operating EBITDA ₹120 cr, up 47%.
- Guidance No specific revenue guidance; long-term blended EBITDA margin seen in mid-20s range.
- New hospitals Srinagar and Kanpur turned EBITDA positive; operating EBITDA ₹15.8 cr in Q2 FY27.
- Working capital Negative ₹172 cr working capital absorption in H1 FY27; DSOs rose to 92 days.
Paras Healthcare Limited Q2 FY27 results
As filed: Revenue ₹413 cr, EBITDA ₹96.3 cr, PAT ₹39.2 cr, EBITDA margin 23.3%.
Not scored. No result for the same quarter last year.
Paras Healthcare Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.